Sales and Marketing/ Views & Analysis/ Views and analysis Finding the right reimbursement model for gene therapies George Underwood CAR T, cell therapy, gene therapy, kantar, Kyrmriah, Luxturna, pricing 0 Comment With cell and gene therapies growing more and more important to healthcare, we sat down with Debbie Warner, Share X Finding the right reimbursement model for gene therapies https://pharmaphorum.com/views-and-analysis/finding-the-right-reimbursement-model-for-gene-therapies/
CAR T, cell therapy, gene therapy, kantar, Kyrmriah, Luxturna, pricing
0 Comment
